Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer

por Corona, Silvia Paola, Generali, Daniele
Publicado 2018

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy

por Sobhani, Navid, Generali, Daniele, Roviello, Giandomenico
Publicado 2017

The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a...

por Roviello, Giandomenico, Generali, Daniele, Sobhani, Navid
Publicado 2019

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer

por Ianza, Anna, Sirico, Marianna, Bernocchi, Ottavia, Generali, Daniele
Publicado 2021

Patients’ Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020

por Palamenghi, Lorenzo, Giudici, Fabiola, Graffigna, Guendalina, Generali, Daniele
Publicado 2022

Breast tumour angiogenesis

por Fox, Stephen B, Generali, Daniele G, Harris, Adrian L
Publicado 2007

Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma

por Sobhani, Navid, Corona, Silvia P., Zanconati, Fabrizio, Generali, Daniele
Publicado 2017

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer

por Sobhani, Navid, Generali, Daniele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Publicado 2018

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer

por Sobhani, Navid, Sirico, Marianna, Generali, Daniele, Zanconati, Fabrizio, Scaggiante, Bruna
Publicado 2020

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

por Sobhani, Navid, Fassl, Anne, Mondani, Giuseppina, Generali, Daniele, Otto, Tobias
Publicado 2021

The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets...

por Rocca, Andrea, Braga, Luca, Volpe, Maria Concetta, Maiocchi, Serena, Generali, Daniele
Publicado 2022

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer

por Roviello, Giandomenico, Corona, Silvia Paola, Bonetta, Alberto, Cappelletti, Maria Rosa, Generali, Daniele
Publicado 2017

The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments

por Sobhani, Navid, Fan, Chunmei, O. Flores-Villanueva, Pedro, Generali, Daniele, Li, Yong
Publicado 2020

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications

por Tierno, Domenico, Grassi, Gabriele, Scomersi, Serena, Bortul, Marina, Generali, Daniele, Zanconati, Fabrizio, Scaggiante, Bruna
Publicado 2023

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

por Cappelletti, Maria Rosa, Gnetti, Letizia, Santini, Daniele, Spada, Daniele, Fox, Stephen B., Generali, Daniele
Publicado 2015

Mutant p53 as an Antigen in Cancer Immunotherapy

por Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Publicado 2020

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

por Sobhani, Navid, Tardiel-Cyril, Dana Rae, Davtyan, Aram, Generali, Daniele, Roudi, Raheleh, Li, Yong
Publicado 2021

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis

por Sobhani, Navid, Roviello, Giandomenico, D’Angelo, Alberto, Roudi, Raheleh, Neeli, Praveen Kumar, Generali, Daniele
Publicado 2021

Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients

por West, Thomas, Cavallero, Corrado, Ceccherini, Rita, Foladore, Silva, Generali, Daniele, Versace, Francesco, Scaggiante, Bruna
Publicado 2022

DNA repair deficiency as circulating biomarker in prostate cancer

por Catalano, Martina, Generali, Daniele, Gatti, Marta, Riboli, Barbara, Paganini, Leda, Nesi, Gabriella, Roviello, Giandomenico
Publicado 2023